Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

At the 2026 Cell-Cell Symposium at UCLA, Partillion Bioscience highlighted its role in advancing a new era of cell-cell interaction mapping. Joe de Rutte, CEO of Partillion Bioscience, presented how ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

Scientists have introduced a microscopy technique that reveals a hidden layer of chemistry involving molecules that normally ...

Claude Mythos Preview is highly skilled at finding software bugs, which could be bad news in the wrong hands, so Anthropic ...

Viventis SCAPE enables fast 3D live cell imaging with gentle conditions, improving reproducibility and throughput for modern ...

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

What if the Trojan horse had been pulled to pieces, revealing the ruse and fending off the invasion, just as it entered the ...

Anthropic said its artificial intelligence model Mythos Preview is not ready for a public launch because of the ways ...

The OEM was able to open up internal capacity by outsourcing to CMP, thereby mitigating the backlog. The manufacturer also ...

Explore how human-relevant tumor models like 3D cultures, organoids, organ-on-chip platforms, and the 3MIC system are ...